Future of Cancer Research: Insights From Women in the Field

September 26, 2023 05:00 AM AEST | By 3BL
Follow us on Google News:

At Baylor Scott & White in Dallas, Texas, Dr. Joyce O’Shaughnessy is a medical oncologist at the forefront of innovative cancer research focusing on advanced treatment options for metastatic triple-negative breast cancer. Meanwhile, thousands of miles away in Madrid, Spain, Dr. Eva Ciruelos leads clinical trials to better understand breast cancer patients who are unresponsive to certain cancer treatments.

In a personal and inspiring conversation, these two trailblazing women in cancer research discuss the critical topic of female-related cancers, what’s on the horizon for their research efforts, and how we can better support women in STEM (science, technology, engineering and mathematics) fields.

Since 1996, the Mary Kay Ash Foundation and Mary Kay Inc. have contributed more than $36 million to cancer research, support programs and services. Across the globe, we are committed to nurturing partnerships aligned with our company’s mission of Enriching Women’s Lives and we are grateful for pioneering women like Dr. Ciruelos and Dr. O’Shaughnessy who help us remain true to our mission.

Listen to their inspiring conversation on our YouTube channel.

I’ve chosen to focus on the primary, resistant triple negative breast cancer. That’s arguably one of our most difficult, scientific biological questions – why is it that some women’s triple negative breast cancer does not respond to the pre-operative therapy? I’m just trying to understand by doing serial biopsies, doing pilot trials of novel therapeutics. Mary Kay has been very supportive of me and others in the U.S. that are working in this area. I really appreciate that because you can’t do it without funding. This is strictly philanthropic funding.

Dr. Joyce O’Shaughnessy, Celebrating Women Endowed Chair in Breast Cancer Research at Baylor University Medical Center

Thanks to Mary Kay for this meeting and many other research ideas and initiatives. Thank you all for being here. Stay tuned because breast cancer is improving and clinical research is the key and the answer to many questions we are ready to solve.

Dr. Eva Ciruelos, Breast Cancer Unit Coordinator, University Hospital/HM Hospitals in Madrid and Chair, SOLTI Group on Breast Cancer Research


The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.

Top ASX Listed Companies

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK